Eli Lilly (LLY) revenue was $65.2B in FY2025 (+45% YoY). The tables below show the complete quarterly and annual revenue history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Revenue
Fiscal Year
Revenue
YoY
2025
$65.2B
+45%
2024
$45.0B
+32%
2023
$34.1B
+20%
2022
$28.5B
+1%
2021
$28.3B
+15%
2020
$24.5B
+10%
2019
$22.3B
+4%
2018
$21.5B
-6%
2017
$22.9B
+8%
2016
$21.2B
+6%
2015
$20.0B
+2%
2014
$19.6B
-15%
2013
$23.1B
+2%
2012
$22.6B
-7%
2011
$24.3B
+5%
2010
$23.1B
+6%
2009
$21.8B
+7%
2008
$20.4B
+9%
2007
$18.6B
Recent Quarterly Revenue
Quarter
Revenue
Q1 2026
$19.8B
Q4 2025
$19.3B
Q3 2025
$17.6B
Q2 2025
$15.6B
Q1 2025
$12.7B
Q4 2024
$13.5B
Q3 2024
$11.4B
Q2 2024
$11.3B
Q1 2024
$8.8B
Q4 2023
$9.4B
Q3 2023
$9.5B
Q2 2023
$8.3B
Source: LLY on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.